Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Immunometabolism

Tonic-ing emissions and compatibility to turbocharge CAR-T

Optimization of energy and carbon–nitrogen allocation maximizes the proliferation and functionality of chimeric antigen receptor (CAR)-T cells. Lakhani et al. report that tonic signalling elements (scFvs) affect CAR-T cell metabolic fitness in an antigen-independent manner. A modest carbon–nitrogen emission (overflow) and resilient metabolic phenotype (compatibility) are associated with effective CAR-T cell therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Tuning tonic signalling and metabolic fitness to enhance CAR-T cell performance.

References

  1. Gnanaprakasam, J. N. R. et al. Nat. Metab. 5, 1423–1439 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Zhao, Y. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-02060-8 (2024).

    Article  PubMed  Google Scholar 

  3. Li, W. et al. Immunity 53, 456–470.e6 (2020).

    Article  CAS  PubMed  Google Scholar 

  4. Kawalekar, O. U. et al. Immunity 44, 380–390 (2016).

    Article  CAS  PubMed  Google Scholar 

  5. Lakhani, A. et al. Nat. Metab. https://doi.org/10.1038/s42255-024-01034-7 (2024).

    Article  Google Scholar 

  6. Bell, H. N. et al. Cell Metab. 35, 134–149.e6 (2023).

    Article  CAS  PubMed  Google Scholar 

  7. Frigault, M. J. et al. Cancer Immunol. Res. 3, 356–367 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Long, A. H. et al. Nat. Med. 21, 581–590 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chen, J. et al. Cell Res. 33, 341–354 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Watanabe, N. et al. OncoImmunology 5, e1253656 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Qiu, S. et al. Cell Res. https://doi.org/10.1038/s41422-024-00936-1 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Chen, X., Liu, L., Kang, S., Gnanaprakasam, J. R. & Wang, R. Sci. Adv. 9, eadd9554 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Wang, H., Song, X., Shen, L., Wang, X. & Xu, C. Trends Cancer 8, 123–134 (2022).

    Article  CAS  PubMed  Google Scholar 

  14. Wang, H., Huang, Y. & Xu, C. Immunol. Rev. 320, 138–146 (2023).

    Article  CAS  PubMed  Google Scholar 

  15. Chen, X. et al. Cancer Immunol. Res. 11, 150–163 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Haopeng Wang or Ruoning Wang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Huang, Y. & Wang, R. Tonic-ing emissions and compatibility to turbocharge CAR-T. Nat Metab (2024). https://doi.org/10.1038/s42255-024-01022-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s42255-024-01022-x

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer